←
Senti Biosciences487 posts
Senti Biosciences avatar

Senti Biosciences

@SentiBio

Outsmarting complex diseases with more intelligent medicines

◷ Joined June 2016▧ 423 Photos and videos
Senti Biosciences avatar
Senti Biosciences@SentiBio·Jul 23

Did you know? Nearly 10% of new cancer cases diagnosed each year in the U.S. are hematologic malignancies, including leukemia, lymphoma and myeloma. #AML remains a serious blood cancer with significant unmet need, underscoring the importance of continued innovation. $SNTI

Post attachment
Senti Biosciences avatar
Senti Biosciences@SentiBio·Jul 16

At Senti, our mission is to create a new generation of smarter medicines designed to outsmart complex diseases. Through innovative Gene Circuit technology, we are advancing novel approaches with the potential to transform patient care. $SNTI #AML #Leukemia #Oncology

0:12
Senti Biosciences avatar
Senti Biosciences@SentiBio·Jun 25

At Senti Bio, we are advancing intelligent Gene Circuits designed for next-generation cell and gene therapies with a focus on oncology. Guided by our values: Be Bold, Better Together, Build to Last. We are working to tackle hard-to-treat diseases. $SNTI #Leukemia #AML #Oncology

Post attachment
Senti Biosciences avatar
Senti Biosciences@SentiBio·Jun 15

AML is the most common type of acute leukemia in adults, accounting for 80% to 85% of cases, with a 5-year survival rate of 31.7% in the United States at diagnosis. $SNTI #AML #Leukemia #Oncology

0:12
Senti Biosciences avatar
Senti Biosciences@SentiBio·May 14

Our Chief Medical Officer, Kanya Rajangam, highlighted strong momentum for SENTI-202, supported by encouraging clinical activity, a favorable safety profile, and advancements in donor selection. Learn more: bit.ly/4wv4mCD $SNTI

Post attachment
Senti Biosciences avatar
Senti Biosciences@SentiBio·May 14

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program bit.ly/4wv4mCD $SNTI

Post attachment
Senti Biosciences avatar
Senti Biosciences@SentiBio·Apr 21

On #AMLWorldAwarenessDay, we recognize the urgency to advance research and bring forward new therapies. Because behind every diagnosis is a life, a family, and a future. We acknowledge the importance of continuing to push science forward to create new possibilities for patients.

Post attachment